ID   Panc 02.05-EYA2
AC   CVCL_C3HL
SY   Panc2.05-EYA2
DR   GEO; GSM823386
DR   Wikidata; Q114312643
RX   PubMed=24810906;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3520; EYA2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; B.cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E278 ! Panc 02.05
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
RX   PubMed=24810906; DOI=10.18632/oncotarget.1842; PMCID=PMC4058028;
RA   Vincent A., Hong S.-M., Hu C.-X., Omura N., Young A., Kim H., Yu J.,
RA   Knight S., Ayars M., Griffith M., Van Seuningen I., Maitra A.,
RA   Goggins M.G.;
RT   "Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes
RT   tumor growth.";
RL   Oncotarget 5:2575-2587(2014).
//